Gross-to-Net Revenue Adjustments for the Pharmaceutical Industry

$49.00

This course will be an overview of:

  • The general principles of the 5-Step Model for recognition of revenue under ASC Topic 606.
  • The components of gross-to-net adjustments to revenue for pharmaceutical and biotech companies including returns, chargebacks, rebates and other adjustments.
  • Certain specialized issues in accounting for revenue recognition in the life sciences industry.

Course Instructors

Timothy F. Gearty

Tim Gearty is the National Director and Editor-in-Chief for the world’s largest CPA training program, Becker CPA Review. In addition to his editorial leadership, Tim is also Becker's National Lead Instructor, whose taped lectures are seen in over 325 locations throughout the world.

Tim is a nationally recognized expert and speaker on a variety of accounting and tax topics, and has appeared as keynote speaker for several Fortune 100 companies as well as many national associations. He has frequently been called upon over the past twenty years to present accounting and tax topics to large groups, organizations, and corporations, accounting firms and in legal proceedings.

Tim is a partner in Gearty & McIntyre, LLP, CPA, a firm which has developed a reputation as a specialist in business advisory services, litigation support and forensic accounting. He is a member of the American Institute of Certified Public Accountants and the New Jersey Society of Public Accountants as well as a trustee of that organization. He holds a BS in Accounting from Fairleigh Dickinson University, and both a MBA in Finance and Law Degree (JD) from Seton Hall University. Tim is a member of the New Jersey and American Bar Associations.

Jack Markey, MBA

Jack has several years of experience in senior managerial roles in accounting policy (U.S. GAAP and IFRS) and in financial reporting, including SEC reporting. He currently serves as the Assistant Controller at Eisai Inc.; an integrated pharmaceutical business with discovery, clinical, manufacturing and marketing capabilities whose key areas of commercial focus include oncology and specialty care products (neurology and metabolic disorders). Prior to Eisai, Jack was the Director of Technical Accounting Research and Tax Accounting for Quest Diagnostics, Inc. and was also the Director of Accounting Policy for Lucent Technologies. His career also includes serving as a manager of financial reporting in a subsidiary of Thermo Electron Corporation and as an auditor for Deloitte & Touche. He is a CPA licensed in the state of New Jersey and previously served as a member of the AICPA’s Financial Reporting Executive Committee (2010-2014). Jack has a B.S. in Accounting and an M.S. in Taxation, both from Fairleigh Dickinson University, Madison, NJ and an MBA from Colorado State University in Ft. Collins, Colorado.

Gross-to-Net Revenue Adjustments for the Pharmaceutical Industry

$49.00

This course will be an overview of:

  • The general principles of the 5-Step Model for recognition of revenue under ASC Topic 606.
  • The components of gross-to-net adjustments to revenue for pharmaceutical and biotech companies including returns, chargebacks, rebates and other adjustments.
  • Certain specialized issues in accounting for revenue recognition in the life sciences industry.

National Registry of CPE Sponsors

A Becker Professional Education is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: www.nasbaregistry.org

Becker Professional Education Sponsor I.D. Numbers NASBA: 107294, New York: 002087, New Jersey: 20CE00226700, Texas: 009580, Ohio: CPE.186, Illinois 158.002405, Pennsylvania: PX177823